We are live on ! Find out more
ACM

ACT Capital Management Portfolio holdings

AUM $153M
This Fund
S&P 500
This Quarter Est. Return
+20.59%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$195M
AUM Growth
–
Cap. Flow
+$180M
Cap. Flow %
92.65%
Top 10 Hldgs %
56.76%
Holding
117
New
116
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
STAA icon
STAAR Surgical
STAA
+$30.5M
2
ARWR icon
Arrowhead Research
ARWR
+$15.5M
3
ARCT icon
Arcturus Therapeutics
ARCT
+$15.4M
4
CLSD
Clearside Biomedical
CLSD
+$7.63M
5
AWH
Aspira Women's Health Inc. Common Stock
AWH
+$6.48M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 79.63%
2 Technology 6.05%
3 Communication Services 5.12%
4 Financials 3.37%
5 Consumer Staples 1.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ZVO
101
DELISTED
Zovio Inc. Common Stock
ZVO
$78K 0.04%
+30,000
New +$91.8K
AVDL
102
DELISTED
Avadel Pharmaceuticals
AVDL
$71K 0.04%
+10,500
New +$83.4K
CLVS
103
DELISTED
Clovis Oncology, Inc.
CLVS
$70K 0.04%
+12,000
New +$70.3K
CLF icon
104
Cleveland-Cliffs
CLF
$7.22B
$65K 0.03%
+3,000
New +$59.1K
HTT
105
High Templar Tech Ltd
HTT
$398M
$61K 0.03%
+25,000
New +$53.5K
QH
106
Quhuo Limited Class A Ordinary Shares
QH
$15.6K
$44K 0.02%
+11
New +$46.9K
AVGR
107
DELISTED
Avinger, Inc. Common Stock
AVGR
$44K 0.02%
+117
New +$40.6K
TMDX icon
108
Transmedics
TMDX
$2.64B
$33K 0.02%
+1,000
New +$27.7K
TECX
109
Tectonic Therapeutic
TECX
$558M
$27K 0.01%
+250
New +$29.6K
ALDX icon
110
Aldeyra Therapeutics
ALDX
$96.5M
$17K 0.01%
+1,500
New +$18K
GNCA
111
DELISTED
Genocea Biosciences, Inc.
GNCA
$12K 0.01%
+5,000
New +$12.1K
PHXM
112
DELISTED
PHAXIAM Therapeutics S.A.. American Depositary Shares
PHXM
$10K 0.01%
+200
New +$12.4K
ABNB icon
113
Airbnb
ABNB
$90.5B
$8K ﹤0.01%
+50
New +$7.84K
EZGO
114
EZGO Technologies
EZGO
$2.15M
– –
0
– –
CYT
115
DELISTED
Cyteir Therapeutics, Inc. Common Stock
CYT
$2K ﹤0.01%
+90
New +$1.69K
AI icon
116
C3.ai
AI
$1.54B
$1K ﹤0.01%
+80
New +$4.97K
1 2 3 4
5

Similar funds

BCI
Blue Capital Inc Omaha, Nebraska $153M AUM 28.69% 1-Year Est. Return
APW
Atlantic Private Wealth Chapel Hill, North Carolina $153M AUM 15.75% 1-Year Est. Return
DAM
Doheny Asset Management Los Angeles, California $153M AUM 42.04% 1-Year Est. Return
BVC
Bright Valley Capital Hong Kong $153M AUM 16.24% 1-Year Est. Return
RHAM
Round Hill Asset Management Pasadena, California $153M AUM 6.67% 1-Year Est. Return
RFN
Redwood Financial Network Solon, Ohio $153M AUM 17.17% 1-Year Est. Return
SGM
Sellaronda Global Management New York $152M AUM 2.1% 1-Year Est. Return
HWM
Horizons Wealth Management Asheville, North Carolina $152M AUM 9.43% 1-Year Est. Return

ACT Capital Management's Q2 2021 Portfolio in Review

Q2 2021 is the first quarter with a 13F filing on record for ACT Capital Management, which disclosed 117 positions worth $195M. Its ten largest holdings account for 57% of the portfolio.

Its largest position is STAAR Surgical: 231,600 shares worth $35.3M.

By sector, the portfolio is most concentrated in Healthcare at 80% of assets, followed by Technology and Communication Services.

  • ACT Capital Management's largest Q2 2021 buy was STAAR Surgical: 231,600 shares worth $35.3M.
  • ACT Capital Management's ten largest holdings make up 57% of its $195M portfolio in Q2 2021.
  • ACT Capital Management disclosed 117 positions in Q2 2021, its first 13F filing on record.

Based on ACT Capital Management's 13F filing for Q2 2021, filed 16 Aug 2021.